Patents by Inventor Maria Vaysberg

Maria Vaysberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEIC ACIDS ENCODING ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20180086845
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: September 5, 2017
    Publication date: March 29, 2018
    Inventors: Scott McCauley, Maria Vaysberg
  • COMPOSITIONS AND METHODS FOR TREATING CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES
    Publication number: 20170306050
    Abstract: The present disclosure provides compositions and methods of use comprising a matrix metalloproteinase-9 (MMP9) binding protein, alone or in combination with one or more additional therapeutic agents for the treatment or prevention of diseases and conditions.
    Type: Application
    Filed: April 7, 2017
    Publication date: October 26, 2017
    Inventors: Jeremiah D. Degenhardt, David Gossage, Andrew Greenstein, Vladi Juric, Amanda Mikels-Vigdal, Victoria Smith, Maria Vaysberg, Peng Yue
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20160159923
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: August 28, 2015
    Publication date: June 9, 2016
    Inventors: Scott McCauley, Maria Vaysberg
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20160122437
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: January 11, 2016
    Publication date: May 5, 2016
    Inventors: Scott Alan McCauley, Maria Vaysberg
  • Antibodies to matrix metalloproteinase 9
    Patent number: 9260532
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: February 16, 2016
    Assignee: Gilead Biologics, Inc.
    Inventors: Scott McCauley, Maria Vaysberg
  • Nucleic acids encoding antibodies to matrix metalloproteinase 9
    Patent number: 9120863
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: September 1, 2015
    Assignee: Gilead Sciences, Inc.
    Inventors: Scott McCauley, Maria Vaysberg
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9 AND METHODS OF USE THEREOF
    Publication number: 20150239988
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), such as where the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: February 25, 2015
    Publication date: August 27, 2015
    Inventors: David L. Gossage, Joseph H. Lin, Victoria Smith, Maria Vaysberg
  • ANTI-DDR1 ANTIBODIES
    Publication number: 20140086913
    Abstract: Provided are antibodies, including functional antibody fragments, that specifically bind to discoidin domain receptors (DDRs), and in particular to DDR1 proteins, as well as uses and method of using such antibodies, including in the detection, diagnosis and treatment of diseases and conditions associated with DDR1.
    Type: Application
    Filed: September 25, 2013
    Publication date: March 27, 2014
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Victoria SMITH, Scott Alan MCCAULEY, Maria VAYSBERG, Joanne I. ADAMKEWICZ
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20130281676
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: July 3, 2013
    Publication date: October 24, 2013
    Inventors: Scott MCCAULEY, Maria VAYSBERG
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20130281675
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: July 3, 2013
    Publication date: October 24, 2013
    Inventors: Scott MCCAULEY, Maria VAYSBERG
  • Antibodies to matrix metalloproteinase 9
    Patent number: 8501916
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: August 6, 2013
    Assignee: Gilead Biologics, Inc.
    Inventors: Scott McCauley, Maria Vaysberg
  • Antibodies to matrix metalloproteinase 9
    Patent number: 8377443
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: February 19, 2013
    Assignee: Gilead Biologics, Inc.
    Inventors: Scott McCauley, Maria Vaysberg
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20130023654
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: September 14, 2012
    Publication date: January 24, 2013
    Applicant: Gilead Biologics, Inc.
    Inventors: Scott MCCAULEY, Maria Vaysberg
  • ANTIBODIES TO MATRIX METALLOPROTEINASE 9
    Publication number: 20120135004
    Abstract: The present disclosure provides compositions and methods of use involving binding proteins, e.g., antibodies and antigen-binding fragments thereof, that bind to the matrix metalloproteinase-9 (MMP9) protein (MMP9 is also known as gelatinase-B), wherein the binding proteins comprise an immunoglobulin (Ig) heavy chain (or functional fragment thereof) and an Ig light chain (or functional fragment thereof).
    Type: Application
    Filed: August 26, 2011
    Publication date: May 31, 2012
    Applicant: Gilead Biologics, Inc.
    Inventors: Scott McCauley, Maria Vaysberg